EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uso de interferón alfa-2b tópico como tratamiento en un caso de neoplasia escamosa de superficie ocular

Daniel Benjamín Mejía Llanes, Nany E. Alvarado H., Luis E. Piche Lozano, Alejandra B. Carranza Rivera

Alerta, Revista científica del Instituto Nacional de Salud · 30.07.2026 · 9 (3) · 184-190

DOI: 10.5377/alerta.v9i3.23326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alerta, Revista científica del Instituto Nacional de Salud, online erschienen am 30.07.2026. Verfasst von Daniel Benjamín Mejía Llanes und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Case presentation. 80 years old male with a history of ocular surface squamous cell neoplasia in his left eye, which was surgically resected ten years ago, was in remission. Referred growth of an ocular surface mass in the same eye following blunt ocular trauma, associated with mild ocular pain, epiphora, and progressive decrease in visual acuity. Upon evaluation, a conjunctiva-corneal neoplasia was identified with 100 % corneal involvement. Treatment. Neoadjuvant treatment with topical interferon alfa-2b 1M IU/ml four times daily was initiated, showing an immunoreduction effect. Computed tomography of the orbit and brain revealed areas of inferior-temporal calcification in the left eye, with no evidence of tumor spread to adjacent tissues. Optical ultrasound showed no tumor spread to the posterior pole. A no-touch excisional biopsy was performed, followed by treatment with 1M IU/ml interferon alfa-2b as adjuvant therapy. One year later, cataract surgery was performed with intraocular lens placement. The final best-corrected visual acuity in the left eye was 20/100 (logMAR 0.70). Outcome. The patient presented with favorable clinical evolution with no evidence of residual disease based on clinical evaluation or optical coherence tomography in the left eye. The patient was placed under oncological surveillance for six months without recurrence.

Zitieren

APA

Llanes, D. B. M., H., N. E. A., Lozano, L. E. P., & Rivera, A. B. C. (2026). Uso de interferón alfa-2b tópico como tratamiento en un caso de neoplasia escamosa de superficie ocular. Alerta, Revista científica del Instituto Nacional de Salud, 9(3), 184-190. https://doi.org/10.5377/alerta.v9i3.23326

Vancouver

Llanes DBM, H. NEA, Lozano LEP, Rivera ABC. Uso de interferón alfa-2b tópico como tratamiento en un caso de neoplasia escamosa de superficie ocular. Alerta, Revista científica del Instituto Nacional de Salud. 2026;9(3):184-190. doi:10.5377/alerta.v9i3.23326

BibTeX
@article{Llanes2026,
  author = {Llanes, Daniel Benjamín Mejía and H., Nany E. Alvarado and Lozano, Luis E. Piche and Rivera, Alejandra B. Carranza},
  title = {Uso de interferón alfa-2b tópico como tratamiento en un caso de neoplasia escamosa de superficie ocular},
  journal = {Alerta, Revista científica del Instituto Nacional de Salud},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {184--190},
  doi = {10.5377/alerta.v9i3.23326}
}
Kostenlos starten →